News-Papers
Testimonial
Video Gallery
Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase
Published on Wednesday, 02 May 2018
Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase
See also:
- Somatostatin in oncology, the overlooked evidences;
- The Di Bella Method (A Fixed Part - Somatostatin, Octreotide, LAR analogues and/or derivatives);
- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Melatonin in the Management of Mood and Sleep Problems Induced by Androgen Deprivation Therapy in Prostate Cancer Patients: A Randomized Double-blinded, Placebo-controlled Clinical Trial
- Mechanisms Underlying Tumor Suppressive Properties of Melatonin
- Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
- In vitro and in vivo antitumor activity of melatonin receptor agonists
- Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
- About melatonin - 1996
- Melatonin as a potential inhibitory agent in head and neck cancer
- Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy
- Metabolic Crosstalk in Triple-Negative Breast Cancer Lung Metastasis: Differential Effects of Vitamin D and E in a Co-Culture System
- Understanding the Mechanism of Action of Melatonin, Which Induces ROS Production in Cancer Cells
- Serum 25-Hydroxyvitamin D Levels in Breast Cancer Patients: A Cross-Sectional Analysis by Molecular Tumor Subtypes
- The Role of Melatonin in Colorectal Cancer
- Assessment of the radioprotective effects of amifostine and melatonin on human lymphocytes irradiated with gamma-rays in vitro
- Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals
- The role of melatonin in immuno-enhancement: potential application in cancer
- Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
- Dose-Dependency of Antitumor Effects of the Pineal Hormone Melatonin in Untreatable Metastatic Solid Tumor Patients
- Beneficial properties of melatonin in an experimental model of pancreatic cancer
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer